Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Cash from Investing Activities: 2020-2024

Historic Cash from Investing Activities for iSpecimen (ISPC) over the last 5 years, with Dec 2024 value amounting to $2.0 million.

  • iSpecimen's Cash from Investing Activities fell 455.71% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$957,892, marking a year-over-year decrease of 172.05%. This contributed to the annual value of $2.0 million for FY2024, which is 127.39% up from last year.
  • Per iSpecimen's latest filing, its Cash from Investing Activities stood at $2.0 million for FY2024, which was up 127.39% from -$7.2 million recorded in FY2023.
  • iSpecimen's Cash from Investing Activities' 5-year high stood at $2.0 million during FY2024, with a 5-year trough of -$7.2 million in FY2023.
  • In the last 3 years, iSpecimen's Cash from Investing Activities had a median value of -$3.2 million in 2022 and averaged -$2.8 million.
  • In the last 5 years, iSpecimen's Cash from Investing Activities crashed by 207.46% in 2022 and then skyrocketed by 127.39% in 2024.
  • iSpecimen's Cash from Investing Activities (Yearly) stood at -$1.1 million in 2020, then rose by 5.87% to -$1.0 million in 2021, then tumbled by 207.46% to -$3.2 million in 2022, then tumbled by 126.51% to -$7.2 million in 2023, then spiked by 127.39% to $2.0 million in 2024.